Yusuke Meguri

421 total citations
32 papers, 285 citations indexed

About

Yusuke Meguri is a scholar working on Immunology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Yusuke Meguri has authored 32 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 17 papers in Hematology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Yusuke Meguri's work include Hematopoietic Stem Cell Transplantation (14 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (10 papers). Yusuke Meguri is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (10 papers). Yusuke Meguri collaborates with scholars based in Japan and United States. Yusuke Meguri's co-authors include Ken‐ichi Matsuoka, Yoshinobu Maeda, Makoto Nakamura, Mitsune Tanimoto, John Koreth, Jerome Ritz, Hideo Yagita∥, Shuntaro Ikegawa, Corey Cutler and Vincent T. Ho and has published in prestigious journals such as Blood, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Yusuke Meguri

28 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yusuke Meguri Japan 9 186 112 81 29 27 32 285
Sébastian Wittnebel France 9 117 0.6× 136 1.2× 81 1.0× 80 2.8× 35 1.3× 19 260
Leah Gehrs United States 7 90 0.5× 94 0.8× 99 1.2× 21 0.7× 37 1.4× 17 194
Qingxiao Song China 8 222 1.2× 96 0.9× 152 1.9× 10 0.3× 36 1.3× 26 310
Vipul Sheth United States 7 84 0.5× 184 1.6× 99 1.2× 14 0.5× 58 2.1× 22 273
Heiko Sic Germany 6 169 0.9× 38 0.3× 30 0.4× 20 0.7× 36 1.3× 6 236
Hongbo Wang United States 8 258 1.4× 154 1.4× 67 0.8× 10 0.3× 46 1.7× 11 311
Noa Tal Israel 6 124 0.7× 100 0.9× 164 2.0× 48 1.7× 63 2.3× 11 356
Masanori Makita Japan 7 139 0.7× 168 1.5× 56 0.7× 90 3.1× 80 3.0× 21 270
Stefanie Bugl Germany 8 164 0.9× 66 0.6× 41 0.5× 21 0.7× 85 3.1× 14 291
Rimke Oostvogels Netherlands 11 254 1.4× 159 1.4× 90 1.1× 47 1.6× 73 2.7× 24 369

Countries citing papers authored by Yusuke Meguri

Since Specialization
Citations

This map shows the geographic impact of Yusuke Meguri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Meguri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Meguri more than expected).

Fields of papers citing papers by Yusuke Meguri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Meguri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Meguri. The network helps show where Yusuke Meguri may publish in the future.

Co-authorship network of co-authors of Yusuke Meguri

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Meguri. A scholar is included among the top collaborators of Yusuke Meguri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Meguri. Yusuke Meguri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Makoto, et al.. (2024). Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified. Journal of Clinical and Experimental Hematopathology. 64(1). 52–58.
2.
Ikegawa, Shuntaro, Midori Filiz Nishimura, Makoto Nakamura, et al.. (2023). Hematopoietic stem cell–derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide. JCI Insight. 8(8). 4 indexed citations
3.
Meguri, Yusuke, et al.. (2022). Spontaneous regression of dasatinib-related primary effusion lymphoma-like lymphoma. International Journal of Hematology. 117(1). 137–142. 3 indexed citations
5.
Kobayashi, Hiroki, Noboru Asada, Daisuke Ennishi, et al.. (2021). Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. International Journal of Hematology. 114(3). 401–407. 3 indexed citations
6.
Matsuoka, Ken‐ichi, Shuntaro Ikegawa, Makoto Nakamura, et al.. (2021). Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Scientific Reports. 11(1). 6420–6420. 3 indexed citations
7.
Nakamura, Makoto, Yusuke Meguri, Shuntaro Ikegawa, et al.. (2021). Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression. Scientific Reports. 11(1). 13125–13125. 10 indexed citations
8.
Ikegawa, Shuntaro, Yusuke Meguri, Makoto Nakamura, et al.. (2020). Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease. Bone Marrow Transplantation. 56(4). 956–959. 10 indexed citations
9.
Matsuoka, Ken‐ichi, Shuntaro Ikegawa, Makoto Nakamura, et al.. (2020). 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Scientific Reports. 10(1). 17237–17237. 13 indexed citations
10.
Fujiwara, Yuki, Ken‐ichi Matsuoka, Yusuke Meguri, et al.. (2020). Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient. International Journal of Hematology. 112(6). 871–877.
11.
Asada, Noboru, Yasuharu Sato, Yusuke Yoshimoto, et al.. (2020). Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: a retrospective case series. International Journal of Hematology. 112(6). 780–786. 6 indexed citations
12.
Kobayashi, Hiroki, Noboru Asada, Yusuke Meguri, et al.. (2020). Adult T-cell Leukemia-lymphoma with Primary Breast Involvement: A Case Report and Literature Review. Internal Medicine. 59(21). 2757–2761. 2 indexed citations
13.
Fujii, Nobuharu, Yusuke Meguri, Makoto Nakamura, et al.. (2020). Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy. International Journal of Hematology. 112(3). 422–426. 4 indexed citations
14.
Matsuoka, Ken‐ichi, Yusuke Meguri, Shuntaro Ikegawa, et al.. (2019). Plasma exchange eliminates residual mogamulizumab but does not warrant prompt recovery of peripheral Treg levels. Transfusion and Apheresis Science. 58(4). 472–474. 2 indexed citations
15.
Ikegawa, Shuntaro, Nobuharu Fujii, Keiko Fujii, et al.. (2018). Granulocyte Transfusions for Neutropenic Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(3). S326–S326.
16.
17.
18.
Meguri, Yusuke, Makoto Nakamura, Hideo Yagita∥, et al.. (2017). PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 129(15). 2186–2197. 127 indexed citations
20.
Meguri, Yusuke, Yoshinobu Maeda, Mitsune Tanimoto, et al.. (2015). Interval of IL-2 Administration Has a Major Impact on Treatment Efficacy for Regulatory T Cell Expansion and Homeostasis. Blood. 126(23). 1928–1928. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026